BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35689522)

  • 1. Curcumin nanoemulsions inhibit oral squamous cell carcinoma cell proliferation by PI3K/Akt/mTOR suppression and miR-199a upregulation: A preliminary study.
    Liu W; Wang J; Zhang C; Bao Z; Wu L
    Oral Dis; 2023 Nov; 29(8):3183-3192. PubMed ID: 35689522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression.
    Zhang G; Wang H; Liu G; Huang J
    Pathol Res Pract; 2024 Jan; 253():155021. PubMed ID: 38103366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
    Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
    Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0058063 Contributed to Oral Squamous Cell Carcinoma Development by Sponging miR-145 and Regulating PI3K/AKT Pathway.
    Zhou J; Jin S
    Mol Biotechnol; 2023 Dec; 65(12):2049-2060. PubMed ID: 36928742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
    Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
    Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.
    Maiti P; Scott J; Sengupta D; Al-Gharaibeh A; Dunbar GL
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
    Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
    Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
    Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
    Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.
    Wei M; Wu Y; Liu H; Xie C
    Drug Des Devel Ther; 2020; 14():395-405. PubMed ID: 32099325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.
    Smolensky D; Rathore K; Bourn J; Cekanova M
    J Cell Biochem; 2017 Sep; 118(9):2615-2624. PubMed ID: 27649518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W; Lai R; Lin Q; Huang Y; Wang L
    J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.